Dermapharm Holding SE logo

Dermapharm Holding SE (DMP)

Market Closed
12 Jun, 20:00
48. 35
+0.7
+1.469%
- Market Cap
28.66 P/E Ratio
- Div Yield
100 Volume
2.25 Eps
47.65
Previous Close
Add Transaction
Day Range
47.6 48.35
Year Range
31.9 50.8
Want to track DMP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DMP closed today higher at €48.35, an increase of 1.469% from yesterday's close, completing a monthly increase of 5.1087% or €2.35. Over the past 12 months, DMP stock gained 23.4994%.
DMP pays dividends to its shareholders, with the most recent payment made on Jul 01, 2025. The next announced payment will be in In 2 weeks on Jul 01, 2026 for a total of €0.88.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on XETRA (EUR).

DMP Chart

Dermapharm Holding SE (DMP) FAQ

What is the stock price today?

The current price is €48.35.

On which exchange is it traded?

Dermapharm Holding SE is listed on XDUS.

What is its stock symbol?

The ticker symbol is DMP.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Dermapharm Holding SE ever had a stock split?

No, there has never been a stock split.

Dermapharm Holding SE Profile

Specialty Retail Industry
Consumer Discretionary Sector
Hans-Georg Feldmeier CEO
XDUS Exchange
DE000A2GS5D8 ISIN
DE Country
3,610 Employees
29 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Dermapharm Holding SE is a distinguished entity in the pharmaceutical sector, specializing in the manufacture and distribution of off-patent branded pharmaceutical products predominantly in Germany. Established in 1991 with its headquarters in Grünwald, Germany, the company operates as a pivotal part of Themis Beteiligungs-AG. Dermapharm distinguishes itself through its operation across three core segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. This diversified approach enables Dermapharm to cater to a broad spectrum of healthcare needs, ensuring a comprehensive portfolio that addresses various medical and health-related concerns.

Products and Services

  • Branded Generics and OTC Products: Dermapharm specializes in offering high-quality branded generic medications and over-the-counter (OTC) healthcare products. These encompass a wide range of therapeutic areas, ensuring access to effective treatments without the need for prescriptions.
  • Non-Prescription Healthcare Products: The company provides a variety of healthcare products that do not require a prescription. This includes items aimed at improving general health and well-being, catering to the needs of consumers seeking accessible healthcare solutions.
  • Herbal Extracts: Leveraging the power of nature, Dermapharm offers herbal extract-based products. These natural remedies are developed to support various health conditions, emphasizing holistic approaches to healthcare.
  • Parallel-Imported Originator Pharmaceuticals: Under the axicorp brand, Dermapharm imports originator pharmaceuticals, offering them to the German market. This segment focuses on providing branded drugs that are sourced from other markets, making them available to patients at potentially lower costs.
  • Vitamins, Minerals, and Food Supplements: Recognizing the importance of nutritional support in health maintenance, Dermapharm provides a vast array of vitamins, minerals, and food supplements. These products are designed to support various aspects of health, including immune system strength, bone health, and overall vitality.
  • Dermatology, Allergology, and Other Therapeutic Areas: Dermapharm's portfolio includes products specifically targeted at treating conditions related to dermatology and allergology, along with pain and inflammation treatment, cardiovascular support, gynecology, and urology. This demonstrates the company's commitment to addressing a wide range of medical needs.
  • Cosmetics and Medical Devices: Beyond pharmaceuticals, Dermapharm also ventures into cosmetics and medical devices. This includes products aimed at enhancing skin health, as well as devices designed for specific medical applications, showcasing the company's versatility in health and wellness.
  • Brands: The company markets its diverse product range under several reputable brands, including Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo. These brands represent Dermapharm's commitment to quality, innovation, and patient care in the healthcare market.

Contact Information

Address: Lil-Dagover-Ring 7
Phone: 49 89 6 41 86 0